2,542
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Bordetella pertussis antigens encapsulated into N-trimethyl chitosan nanoparticulate systems as a novel intranasal pertussis vaccine

, , , , , , , & show all
Pages 2605-2611 | Received 29 Mar 2019, Accepted 29 May 2019, Published online: 26 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tuksin Jearanaiwitayakul, Panya Sunintaboon, Runglawan Chawengkittikul, Jitra Limthongkul, Panuwat Midoeng, Preamrudee Chaisuwirat, Saradee warit & Sukathida Ubol. (2021) Whole inactivated dengue virus-loaded trimethyl chitosan nanoparticle-based vaccine: immunogenic properties in ex vivo and in vivo models. Human Vaccines & Immunotherapeutics 17:8, pages 2793-2807.
Read now
Zohre Sadeghi, Mahdi Fasihi-Ramandi & Saeid Bouzari. (2020) Nanoparticle-Based Vaccines for Brucellosis: Calcium Phosphate Nanoparticles-Adsorbed Antigens Induce Cross Protective Response in Mice. International Journal of Nanomedicine 15, pages 3877-3886.
Read now

Articles from other publishers (14)

Zhidong Zhou, Mingxuan Kai, Shuyan Wang, Dan Wang, Yifei Peng, Yiyan Yu, Weiwei Gao & Liangfang Zhang. (2023) Emerging nanoparticle designs against bacterial infections. WIREs Nanomedicine and Nanobiotechnology 15:4.
Crossref
Colleen J. Sedney & Eric T. Harvill. (2023) The Neonatal Immune System and Respiratory Pathogens. Microorganisms 11:6, pages 1597.
Crossref
Maryam Rezaei, Fariba Esmaeili, Mohammad Reza Asadi Karam, Parastoo Ehsani, Zeinab Abbasnezhad Farsangi & Saeid Bouzari. (2023) In silico design and in vivo evaluation of two multi-epitope vaccines containing build-in adjuvant with chitosan nanoparticles against uropathogenic Escherichia coli. International Immunopharmacology 117, pages 109999.
Crossref
Alireza Ranjbariyan, Setareh Haghighat, Mohammad Hossein Yazdi & Sepideh Arbabi Bidgoli. (2022) Synthetic selenium nanoparticles as co-adjuvant improved immune responses against methicillin-resistant Staphylococcus aureus. World Journal of Microbiology and Biotechnology 39:1.
Crossref
Melika HaghighiAkbar Khorasani, Pegah KarimiRouhollah KeshavarzMehdi Mahdavi. (2022) Different Formulations of Inactivated SARS-CoV-2 Vaccine Candidates in Human Compatible Adjuvants: Potency Studies in Mice Showed Different Platforms of Immune Responses. Viral Immunology 35:10, pages 663-672.
Crossref
Isra Dmour & Nazrul Islam. (2022) Recent advances on chitosan as an adjuvant for vaccine delivery. International Journal of Biological Macromolecules 200, pages 498-519.
Crossref
M. Verónica Rivas, Adriana Kolender & Norma Beatriz D’Accorso. 2022. Chitosan in Drug Delivery. Chitosan in Drug Delivery 501 518 .
Tuksin Jearanaiwitayakul, Suttikarn Apichirapokey, Runglawan Chawengkirttikul, Jitra Limthongkul, Mathurin Seesen, Phissinee Jakaew, Sakalin Trisiriwanich, Sompong Sapsutthipas, Panya Sunintaboon & Sukathida Ubol. (2021) Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract. Viruses 13:11, pages 2202.
Crossref
Anahita Rahimkhani, Setareh Haghighat, Hassan Noorbazargan & Mehdi Mahdavi. (2021) Improvement of hepatitis B vaccine to induce IFN-γ cytokine response: A new formulation. Microbial Pathogenesis 160, pages 105184.
Crossref
Tuksin Jearanaiwitayakul, Mathurin Seesen, Runglawan Chawengkirttikul, Jitra Limthongkul, Suttikarn Apichirapokey, Sompong Sapsutthipas, Supaporn Phumiamorn, Panya Sunintaboon & Sukathida Ubol. (2021) Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2. Vaccines 9:7, pages 768.
Crossref
Wieslaw Swietnicki. (2021) Secretory System Components as Potential Prophylactic Targets for Bacterial Pathogens. Biomolecules 11:6, pages 892.
Crossref
Violaine Dubois & Camille Locht. (2021) Mucosal Immunization Against Pertussis: Lessons From the Past and Perspectives. Frontiers in Immunology 12.
Crossref
Youming Xiong, Meng Xiong, Yangyang Li, Jin Qian, Yuwei Li, Xu Han, Jing Tan, Yanli Luo, Qiuxiang Wang & Caiqin Qin. (2020) Chitosan oligosaccharide combined with running benefited the immune status of rats. International Immunopharmacology 88, pages 106915.
Crossref
Farhad Gilavand, Abdolrazagh Marzban, Gholamhossein Ebrahimipour, Neda Soleimani & Mehdi Goudarzi. (2020) Designation of chitosan nano-vaccine based on MxiH antigen of Shigella flexneri with increased immunization capacity. Carbohydrate Polymers 232, pages 115813.
Crossref